5,6-dimethyl-3,4-dihydro-2H-pyran | 15990-80-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 氧杂环化合物
• 英文名称: 5,6-dimethyl-3,4-dihydro-2H-pyran
• 英文别名: 2.3-Dimethyl-Δ²-dihydropyran；2,3-Dimethyl-5,6-dihydro-γ-pyran；5,6-dimethyl-3,4-dihydro-2H-pyran
• CAS: 15990-80-4
• 化学式: C₇H₁₂O
• 分子量: 112.172
• InChiKey: NUMHTFWDDUIQTR-UHFFFAOYSA-N

物化性质

• 沸点：
  132 °C
• 密度：
  0.884±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5,6-dimethyl-3,4-dihydro-2H-pyran 在 盐酸 作用下， 生成 6-hydroxy-3-methyl-hexan-2-one
  参考文献：
  名称：

  Trubnikov,I.S.; Pentin,Yu.A., Journal of general chemistry of the USSR, 1962, vol. 32, # 11, p. 3523 - 3526

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 生成 5,6-dimethyl-3,4-dihydro-2H-pyran
  参考文献：
  名称：

  Sachs, Chemische Berichte, 1899, vol. 32, p. 62

  摘要：

  DOI：

文献信息

• Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
  申请人：Vertex Pharmaceuticals Incorporated

  公开号：US20150231142A1

  公开（公告）日：2015-08-20

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及含有上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
  申请人：Van Goor Fredrick F.

  公开号：US20110098311A1

  公开（公告）日：2011-04-28

  The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.

  本发明涉及包含上皮钠通道活性抑制剂与至少一种ABC转运蛋白调节剂化合物（A式、B式、C式或D式）的药物组合物。该发明还涉及这些药物配方，以及使用这些组合物治疗CFTR介导的疾病，特别是囊性纤维化的方法。
• [EN] HYDANTOIN MODULATORS OF KV3 CHANNELS<br/>[FR] HYDANTOÏNES UTILISÉES EN TANT QUE MODULATEURS DE CANAUX KV3
  申请人：AUTIFONY THERAPEUTICS LTD

  公开号：WO2017103604A1

  公开（公告）日：2017-06-22

  The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

  该发明提供了式(I)的化合物：所述化合物是Kv3通道的抑制剂，可用于预防或治疗相关疾病。
• GSK-3BETAINHIBITOR
  申请人：Itoh Fumio

  公开号：US20100069381A1

  公开（公告）日：2010-03-18

  For the purpose of providing a GSK-3β inhibitor containing an oxadiazole compound or a salt thereof or a prodrug thereof useful as an agent for the prophylaxis or treatment of a GSK-3β-related pathology or disease, the present invention provides a GSK-3β inhibitor containing a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof or a prodrug thereof.

  为了提供一种含有噁二唑化合物或其盐或其前药的GSK-3β抑制剂，用作GSK-3β相关病理或疾病的预防或治疗剂，本发明提供了一种含有由以下式（I）表示的化合物的GSK-3β抑制剂： 其中每个符号如规范中定义，或其盐或其前药。
• PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATION THEREOF
  申请人：Barre Lionel

  公开号：US20080021070A1

  公开（公告）日：2008-01-24

  The invention relates to compounds of formula (I): Wherein Z, R 3 to R 9 are as described herein. The invention also relates to methods of preparation of compounds of formula (I) and intermediates thereof. The compounds of this invention are active at CB1 cannabinoid receptor site, and are therefore, useful as pharmaceutical agents in treating a variety of diseases caused by the effects of CB1 cannabinoid receptors.

  这项发明涉及式(I)的化合物： 其中Z，R3至R9如本文所述。该发明还涉及制备式(I)化合物及其中间体的方法。本发明的化合物在CB1大麻素受体位点具有活性，因此在治疗由CB1大麻素受体效应引起的各种疾病中作为药用剂是有用的。